ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionPhoenix Holdings Ltd.
Latest Disclosed Ownership1,402 shares
Latest Disclosed Value $ 314,721
Phoenix Holdings Ltd. reports 22.13% increase in ownership of RMD / ResMed Inc.

On May 11, 2026 - Phoenix Holdings Ltd. filed a 13F-HR form disclosing ownership of 1,402 shares of ResMed Inc. (MX:RMD) valued at $314,721 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 1,148 shares of ResMed Inc.. This represents a change in shares of 22.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F RESMED COM 761152107 1,402 254 22.13 315 13.77 0.0019
2026-02-05 2025-12-31 13F RESMED COM 761152107 1,148 178 18.35 277 4.15 0.0019
2025-11-13 2025-09-30 13F/A-2 RESMED COM 761152107 970 85 9.60 266 16.23 0.0032
2025-11-13 2025-09-30 13F/A-1 RESMED COM 761152107 970 85 266 0.0022
2025-11-03 2025-09-30 13F RESMED COM 761152107 970 85 266 0.0022
2025-07-30 2025-06-30 13F RESMED COM 761152107 885 885 228 0.0030
2023-02-13 2022-12-31 13F RESMED COM 761152107 0 -2,949 -100.00 0 -100.00
2022-11-10 2022-09-30 13F RESMED COM 761152107 2,949 252 9.34 646 14.13 0.0142
2022-08-15 2022-06-30 13F RESMED COM 761152107 2,697 1,774 192.20 566 151.56 0.0116
2022-05-10 2022-03-31 13F RESMED COM 761152107 923 -400 -30.23 225 -34.97 0.0029
2022-05-10 2022-03-31 13F RESMED COM 761152107 2,476 602
2022-02-07 2021-12-31 13F RESMED COM 761152107 1,323 -283 -17.62 346 -18.59 0.0057
2021-10-27 2021-09-30 13F RESMED COM 761152107 1,606 1,606 425 0.0074
2021-08-10 2021-06-30 13F RESMED COM 761152107 0 -1,878 -100.00 0 -100.00
2021-05-10 2021-03-31 13F RESMED COM 761152107 1,878 -708 -27.38 356 -34.07 0.0080
2021-02-11 2020-12-31 13F RESMED COM 761152107 2,586 1,025 65.66 540 112.60 0.0145
2020-11-10 2020-09-30 13F RESMED COM 761152107 1,561 -1,507 -49.12 254 -53.39 0.0106
2020-08-10 2020-06-30 13F RESMED COM 761152107 3,068 3,068 545 0.0231
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.